Neurolens announced the appointment of Thomas J. Chirillo as Chief Commercial Officer. An accomplished senior healthcare executive with deep experience in the eye care space, Mr. Chirillo brings almost 4 decades of sales and marketing experience to neurolens.
“We’re thrilled to have someone with Tom’s experience help drive growth for neurolens among eye care providers as we expand commercialization nationwide,” Davis Corley, neurolens President, said in a company news release.
Neurolenses are the first and only prescription lenses that add a contoured prism to treat the headaches, neck/shoulder pain, and eyestrain, which 65 percent of U.S. adults complain of when using digital devices, reading or doing detail work, according to neurolens. With American adults now spending more than nine hours a day on digital devices, the number of affected individuals has grown, and symptom relief is desperately desired by many.
Prior to joining neurolens, Mr. Chirillo served as Senior Vice President, Sales and Marketing for TearScience. There he drove the company’s turnaround, changing its business model and significantly driving sales and customer growth, which led to the company’s acquisition. Additionally, Mr. Chirillo was part of the management team that founded NovaMed during the first wave of eyecare consolidation. He spent 16 years at NovaMed from the company’s beginning through its initial public offering, leading the development team and driving growth through ambulatory surgery center initiatives as well as corporate acquisitions. At neurolens, Mr. Chirillo will oversee new market development and drive the availability of neurolens at eye care providers across the U.S.
To learn more about neurolenses or to find a neurolenses eye care provider, visit neurolenses.com.